Literature DB >> 9187152

Parthenogenetic activation of mouse eggs by microinjection of a truncated c-kit tyrosine kinase present in spermatozoa.

C Sette1, A Bevilacqua, A Bianchini, F Mangia, R Geremia, P Rossi.   

Abstract

A truncated form of the c-kit tyrosine kinase receptor, corresponding to the phosphotransferase portion of the cytoplasmic catalytic domain and the carboxyterminus (tr-kit), is accumulated during late mouse spermiogenesis. Here we report that tr-kit is specifically localized in the residual sperm cytoplasm, with maximal accumulation in the midpiece of the flagellum, suggesting that it can enter the egg during fertilization. Microinjection of extracts from COS cells expressing a recombinant tr-kit protein into metaphase II-arrested mouse oocytes caused complete oocyte activation, including cortical granule exocytosis, completion of the 2nd meiotic division, formation of a parthenogenetic pronucleus and progression through cleavage stages. No activation above background levels was obtained with extracts from mock-transfected COS cells. Similar results were obtained by microinjection of in vitro synthesized tr-kit mRNA into metaphase II-arrested oocytes. Tr-kit-induced parthenogenetic egg activation was completely inhibited by oocyte preincubation with the Ca2(+)-chelating agent BAPTA-AM or with a specific inhibitor of phospholipase C activity. Tr-kit-induced egg activation was associated with a decrease in activity of mitogen-activated protein kinase, an essential component of the cytostatic factor. These results candidate tr-kit as a putative sperm factor required for triggering activation of mouse eggs at fertilization.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9187152     DOI: 10.1242/dev.124.11.2267

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  32 in total

1.  The soluble sperm factor that causes Ca2+ release from sea-urchin (Lytechinus pictus) egg homogenates also triggers Ca2+ oscillations after injection into mouse eggs.

Authors:  J Parrington; K T Jones; A Lai; K Swann
Journal:  Biochem J       Date:  1999-07-01       Impact factor: 3.857

2.  Spermatogenesis in mice carrying Dominant Spotting Yurlovo, a c-kit gene mutation.

Authors:  T N Chebotareva; L F Kurilo; A M Malashenko; N Yu Sakharova; L M Chailakhyan
Journal:  Dokl Biol Sci       Date:  2002 Nov-Dec

3.  c-kit and its related genes in spermatogonial differentiation.

Authors:  Lei Zhang; Jiangjing Tang; Christopher J Haines; Huai L Feng; Liangxue Lai; Xiaoming Teng; Yibing Han
Journal:  Spermatogenesis       Date:  2011-07-01

4.  Paternal RNA contributions in the Caenorhabditis elegans zygote.

Authors:  Marlon Stoeckius; Dominic Grün; Nikolaus Rajewsky
Journal:  EMBO J       Date:  2014-06-03       Impact factor: 11.598

Review 5.  The eggstraordinary story of how life begins.

Authors:  John Parrington; Christophe Arnoult; Rafael A Fissore
Journal:  Mol Reprod Dev       Date:  2018-11-30       Impact factor: 2.609

Review 6.  Structural and functional properties of platelet-derived growth factor and stem cell factor receptors.

Authors:  Carl-Henrik Heldin; Johan Lennartsson
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-08-01       Impact factor: 10.005

7.  Tr-kit-induced resumption of the cell cycle in mouse eggs requires activation of a Src-like kinase.

Authors:  Claudio Sette; Maria Paola Paronetto; Marco Barchi; Arturo Bevilacqua; Raffaele Geremia; Pellegrino Rossi
Journal:  EMBO J       Date:  2002-10-15       Impact factor: 11.598

Review 8.  Role of c-kit in mammalian spermatogenesis.

Authors:  P Rossi; C Sette; S Dolci; R Geremia
Journal:  J Endocrinol Invest       Date:  2000-10       Impact factor: 4.256

Review 9.  Increasing associations between defects in phospholipase C zeta and conditions of male infertility: not just ICSI failure?

Authors:  Junaid Kashir
Journal:  J Assist Reprod Genet       Date:  2020-04-14       Impact factor: 3.412

Review 10.  Impact of marine drugs on animal reproductive processes.

Authors:  Francesco Silvestre; Elisabetta Tosti
Journal:  Mar Drugs       Date:  2009-11-06       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.